A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

Clinical trial NCT05620823 · COMPLETED

Trial details

NCT number: NCT05620823
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hidradenitis Suppurativa (HS)

Start date: 2022-12-19
Primary completion: 2025-02-03
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.